On January 17, 2023, InDevR, Inc. closed the transaction. The transaction included participation from returning investor Adjuvant Capital, LP of $4 million, and new investor bioMérieux S.A. of $5 million. As a part of the transaction, Michael Reynier of bioMérieux S.A. joins the board seat.

The company has received $5,999,975 pursuant to form D. The transaction included participation from four investors.